[{"Assets_0_Q3_USD":160416000.0,"CommonStockSharesOutstanding_0_Q3_shares":41380811.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-76055000.0,"NetIncomeLoss_1_Q3_USD":-55319000.0,"NetIncomeLoss_3_Q3_USD":-142760000.0,"StockholdersEquity_0_Q3_USD":85275000.0,"Ticker":"ACRS","CIK":"1557746","name":"ACLARIS THERAPEUTICS, INC.","OfficialName":"Aclaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1075670582.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]